Clover Health Investments (CLOV) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Exagen (XGN) over the past year, gaining 64.7% versus a loss of 25.6%. Over five years, XGN leads with a -35.3% price change compared with -42.4% for CLOV. Clover Health Investments is the larger company by market cap ($2.43 billion vs $197.9 million), about 12.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | XGN |
|---|---|---|
| Share price | $4.58 | $8.17 |
| Market cap | $2.43B | $197.92M |
| 1-day change | +0.44% | -1.57% |
| YTD return | +94.89% | +34.38% |
| 1-year return | +64.75% | -25.59% |
| 5-year return | -42.35% | -35.31% |
| Forward P/E | 30.53 | — |
| EPS (TTM) | $-0.05 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.92B | — |
| Revenue growth (YoY) | +40.34% | — |
| Net income (latest FY) | $-85.55M | — |
| Operating margin | -4.44% | — |
| Net margin | -4.45% | — |
| 52-week high | $5.59 | $12.23 |
| 52-week low | $1.58 | $2.59 |
| Distance from 52-week high | -18.07% | -33.20% |
| Analyst consensus | none | none |
| Avg. price target upside | +17.47% | +24.11% |
| Average volume | 4.27M | 328.42K |
| Shares outstanding | 435.44M | 24.23M |
| Employees | 724 | 216 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Clover Health Investments is about 12.3 times larger than Exagen by market value ($2.43B vs $197.92M).
- CLOV has outperformed XGN by 90.3 percentage points over the past year.
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Health Care · Medical Specialities · 724 employees
About Exagen
XGN stock →Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Health Care · Medical Specialities · 216 employees
CLOV vs XGN FAQ
Which is bigger, Clover Health Investments or Exagen?
Clover Health Investments (CLOV) is larger, with a market capitalization of $2.43B compared with $197.92M for Exagen (XGN).
Which stock has performed better over the past year, CLOV or XGN?
CLOV returned +64.75% over the past 12 months, compared with -25.59% for XGN (price return, excluding dividends). Past performance does not predict future results.
Are Clover Health Investments and Exagen in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.